Cargando…
High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer
Immune checkpoint blockade (ICB) improves survival in many types of cancers including melanoma, non-small cell lung, renal cell, breast, and cervical cancers. However, many of these therapies are also associated with high grade dermatologic adverse events (DAEs), including Stevens-Johnson syndrome a...
Autores principales: | Kuo, Alyce M., Markova, Alina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234653/ https://www.ncbi.nlm.nih.gov/pubmed/35770005 http://dx.doi.org/10.3389/fmed.2022.898790 |
Ejemplares similares
-
Management of immune checkpoint inhibitor‐related dermatologic adverse events
por: Si, Xiaoyan, et al.
Publicado: (2019) -
A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy
por: Parisi, Rose, et al.
Publicado: (2023) -
Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events
por: Nakamura, Yoshiyuki
Publicado: (2019) -
Clinical and Hematological Predictors of High-Grade Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors
por: Manne, Ashish, et al.
Publicado: (2021) -
Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint Blockade
por: Hu, Weilei, et al.
Publicado: (2020)